MUCUS RELIEF
NDC 72090-035, guaifenesin 400 mg, tablet, from Pioneer Life Sciences, LLC.
- Product NDC
- 72090-035
- Status
- Listed
- Labeler
- Pioneer Life Sciences, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72090-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72090-035-01 | 72090003501 | 200 TABLET in 1 BOTTLE (72090-035-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 72090-035 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72090-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72090-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.